Daniel E. Spratt

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

2022 · Research Square

<title>Abstract</title> Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood …